D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Custom Truck One Source
CTOS
$2.47B
| $185K | ﹤0.01% |
+29,971
| New | +$177K |
|
3752
iQIYI
IQ
$1.18B
| $185K | ﹤0.01% |
37,873
-375,468
| -91% | -$1.77M |
|
3753
EverCommerce
EVCM
$2.05B
| $184K | ﹤0.01% |
16,702
-13,633
| -45% | -$131K |
|
|
BRSP
3754
BrightSpire Capital
BRSP
$681M
| $184K | ﹤0.01% |
24,696
+4,078
| +20% | +$26.6K |
|
|
SEMR
3755
DELISTED
Semrush
SEMR
| $184K | ﹤0.01% |
+13,434
| New | +$133K |
|
3756
BioCryst Pharmaceuticals
BCRX
$2.37B
| $183K | ﹤0.01% |
+30,631
| New | +$177K |
|
3757
Adeia
ADEA
$2.86B
| $179K | ﹤0.01% |
14,442
-63,251
| -81% | -$611K |
|
|
TPC
3758
Tutor Perini Cor
TPC
$4.57B
| $177K | ﹤0.01% |
19,461
-25,020
| -56% | -$199K |
|
3759
Caesarstone
CSTE
$72.3M
| $177K | ﹤0.01% |
47,329
-19,007
| -29% | -$76.7K |
|
3760
AbCellera Biologics
ABCL
$1.62B
| $175K | ﹤0.01% |
30,633
-404,720
| -93% | -$1.88M |
|
|
BLFY
3761
DELISTED
Blue Foundry Bancorp
BLFY
| $174K | ﹤0.01% |
18,014
| – | – |
|
|
KLRS
3762
Kalaris Therapeutics
KLRS
$88.7M
| $172K | ﹤0.01% |
+10,984
| New | +$433K |
|
3763
SES AI Corp Warrants
SES.WS
$4.82M
| $170K | ﹤0.01% |
988,099
| – | – |
|
|
MURA
3764
DELISTED
Mural Oncology
MURA
| $168K | ﹤0.01% |
+28,427
| New | +$114K |
|
3765
Olema Pharmaceuticals
OLMA
$1.02B
| $167K | ﹤0.01% |
+11,889
| New | +$160K |
|
|
MTA
3766
Metalla Royalty & Streaming
MTA
$704M
| $160K | ﹤0.01% |
52,038
+29,107
| +127% | +$86.7K |
|
|
HYZN
3767
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $160K | ﹤0.01% |
+3,581
| New | +$179K |
|
3768
PLAYSTUDIOS Inc
MYPS
$79.3M
| $159K | ﹤0.01% |
+58,809
| New | +$160K |
|
|
VOXX
3769
DELISTED
VOXX International Corporation Class A
VOXX
| $159K | ﹤0.01% |
14,909
-197
| -1% | -$1.95K |
|
3770
Vuzix
VUZI
$190M
| $159K | ﹤0.01% |
+76,146
| New | +$208K |
|
3771
Life Time Group Holdings
LTH
$9.42B
| $159K | ﹤0.01% |
10,524
-90,253
| -90% | -$1.3M |
|
3772
Acrivon Therapeutics
ACRV
$68.5M
| $157K | ﹤0.01% |
31,939
-14,811
| -32% | -$78.2K |
|
3773
Accel Entertainment
ACEL
$979M
| $157K | ﹤0.01% |
15,278
-36,300
| -70% | -$374K |
|
|
ETNB
3774
DELISTED
89bio
ETNB
| $156K | ﹤0.01% |
13,957
-4,348
| -24% | -$40K |
|
3775
Star Holdings Shares of Beneficial Interest
STHO
$112M
| $154K | ﹤0.01% |
10,271
-2,630
| -20% | -$32.8K |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.